BPC-157 Peptide and TB-500 Peptide

Certificate of Analysis

Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to ensure accuracy, purity, and that all specifications are met.

BPC-157

• Purity: 99.85%
• Date: 07/03/2025

TB-500

• Purity: 99.42%
• Date: 03/27/2025

View all COAs at the bottom of this tab.

BPC-157 Data

• Purity: Our BPC-157 Peptide is produced to the highest standards of purity, ensuring accurate and reliable research results.
• Form: We provide lyophilized powder for easy handling and extended shelf life.
• Solubility: Highly soluble in bacteriostatic water, allowing for convenient preparation of research solutions.
• Storage: Store the peptide in a cool, dry place, away from light, for extended stability. Refrigerate after reconstitution
• CAS Number: 137525-51-0
• Molecular Weight: 1,419.5 g/mol
• Class: Polypeptide
• Formula: C₆₂H₉₈N₁₆O₂₂
• Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

TB500 Data

• Purity: Our TB500 Peptide is produced to the highest standards of purity, ensuring accurate and reliable research results.
• Form: We provide lyophilized powder for easy handling and extended shelf life.
• Solubility: Highly soluble in water, allowing for convenient preparation of research solutions.
• Storage: Store the peptide in a cool, dry place, away from light, for extended stability. Refrigerate after reconstitution.
• CAS Number: 77591-33-4
• Molecular Weight: 4963.49 g/mol
• Class: Polypeptide
• Formula: C212H350N56O78S

Scientific References:

1. Sikiric P, Seiwerth S, Grabarevic Z, et al. BPC 157’s effect on healing. Journal of Physiology and Pharmacology. 2009 Dec;60(Suppl 7): Suppl 2: 191-6. PMID: 20572349.

2. Chang CH, Tsai WC, Lin MS, et al. Effects of pentadecapeptide BPC 157 on tendon healing in a rat model. Journal of Orthopaedic Research. 2011 Aug;29(8): 1174-80. Doi: 10.1002/jor.21367.

3. Klicek R, Sever M, Radic B, et al. Gastric pentadecapeptide BPC-157 accelerates the healing of transected rat Achilles tendons and in vitro stimulates tendocyte growth. Journal of Orthopaedic Research. 2003;21(6):976-83. Doi: 10.1016/S0736-0266(03)00081-1.

4. Mogoşanu, G. D., & Grumezescu, A. M. (2014). Natural and synthetic polymers for wound and burn dressing. International journal of pharmaceutics, 463(2), 127-136.

5. Krivic A, Anic T, Seiwerth S, et al. Achilles Detachment in Rat and Stable Gastric Pentadecapeptide BPC-157: Promoted Tendon-to-Bone Healing and Opposed Corticosteroid Adverse Effects. Journal of Orthopaedic Research. 2006 Jun;24(6):982-93. Doi: 10.1002/jor.20096.

6. Chang, C. H., Tsai, W. C., Lin, M. S., Hsu, Y. H., & Pang, J. H. S. (2011). The promoting effect of pentadecapeptide BPC-157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 110(3), 774-780.

7. Duzel, A., Vlainic, J., Antunovic, M., Malekinusic, D., Vrdoljak, B., Samara, M., … & Sikiric, P. (2017). Stable gastric pentadecapeptide BPC-157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World Journal of Gastroenterology, 23(48), 8465.

8. Sikiric P, et al. Stable gastric pentadecapeptide BPC-157 in the treatment of colitis and ischemia and reperfusion in rats: new insights. World Journal of Gastroenterology. 2017;23(48): 8465-8488. doi: 10.3748/wjg.v23.i48.8465.

9. Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL14736) (gep-bpc-157). Current Pharmaceutical Design. 2018;24(2): 190-195. Doi: 10.2174/1381612823666170829095955.

10. Stupnisek M, et al. Pentadecapeptide BPC-157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colo-rectal fistulas in rats: role of the nitric oxide system. Journal of Pharmacological Sciences. 2017;133(4): 201-208. doi: 10.1016/j.jphs.2017.07.009.

11. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005 Aug;11(8): 354-61.

12. Post A, Al-Rawi M, Sumitran-Holgersson S. In vivo tissue repair activity of thymosin beta-4 in wound healing. Annals of the New York Academy of Sciences. 2007 Sep;1112: 177-81. doi: 10.1196/annals. 1415.019.

13. Hinkel, R., El-Aouni, C., Olson, T., Horstkotte, J., Mayer, S., Müller, S., … & Kupatt, C. (2008). Thymosin β4 is an essential paracrine factor of embryonic endothelial progenitor cell–mediated cardioprotection. Circulation, 117(17), 2232-2240.

14. Belsky, J. B., Rivers, E. P., Filbin, M. R., Lee, P. J., & Morris, D. C. (2018). Thymosin beta 4 regulation of actin in sepsis. Expert opinion on biological therapy, 18(sup1), 193-197.

15. Bock-Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004 Apr;432(7016): 466-72. doi: 10.1038/nature03000.

16. Goldstein, A. L., Hannappel, E., Sosne, G., & Kleinman, H. K. (2012). Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert opinion on biological therapy, 12(1), 37-51.

17. Sosne, G., Rimmer, D., Kleinman, H. K., & Ousler, G. (2016). Thymosin beta 4: a potential novel therapy for neurotrophic keratopathy, dry eye, and ocular surface diseases. Vitamins and hormones, 102, 277-306.

18. Smart, N., Risebro, C. A., Melville, A. A., Moses, K., Schwartz, R. J., Chien, K. R., & Riley, P. R. (2007). Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization. Nature, 445(7124), 177-182.

Please note that the above references provide evidence for the potential benefits of BPC-157 Peptide and Ipamorelin Peptide as stated in the product description. For more in-depth information, refer to these scholarly works.